For a 55-year-old primary prevention patient who is statin-eligible under the pooled cohort equations (10-year risk 9%) but reclassified to borderline risk (5%) by PREVENT — with no outcomes trial showing it's safe to withhold therapy in the reclassified-down group — do you defer the statin based on the new equations, or treat to the old threshold and use PREVENT only to escalate, never to de-escalate?
Heat
Resolution
No fixed date yet
Sources
0
How this gets settled
⤢
Resolving trial — not yet identified
Resolution
No fixed date yet
The debate
⤢
Camps not yet extracted — awaiting next scan
Who could settle it
⤢
Know an expert who could settle this? Suggest one →
Get involved
Preview⤢
Not yet tracked
WatchSteer thisSoon
Sources & verification
⤢
1linked & dated sources
VerifiedConfirmed against a primary source (registry API or dual-model citation gate).EstimateA computed estimate (e.g. comparable-based cost or modeled range), not a measured value.Scan-reportedReported by the scan and linked to its source — not yet independently verified.
For a 55-year-old primary prevention patient who is statin-eligible under the pooled cohort equations (10-year risk 9%) but reclassified to borderline risk (5%) by PREVENT — with no outcomes trial showing it's safe to withhold therapy in the reclassified-down group — do you defer the statin based on the new equations, or treat to the old threshold and use PREVENT only to escalate, never to de-escalate? | Synapse Debates